SWEtick - a Prospective Multicenter Study of Tick-borne Diseases in Sweden
NCT06781008 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 600
Last updated 2026-03-05
Summary
The purpose of the SWEtick project is to increase the knowledge of the various clinical presentations of emerging tick-borne diseases (eTBD), to assess their importance for human health, to develop and validate laboratory methods for diagnosis of eTBD, and to develop recommendations for knowledge-driven management of patients with suspected eTBD within the Swedish healthcare system.
Conditions
- Tick-Borne Diseases
Sponsors & Collaborators
-
Region Östergötland
collaborator OTHER -
Region Kalmar County
collaborator UNKNOWN -
Region Dalarna
collaborator UNKNOWN -
FORSS - The Research Council of South-Eastern Sweden
collaborator UNKNOWN -
ALF Grants, Region Östergötland
collaborator UNKNOWN -
Linkoeping University
collaborator OTHER_GOV -
Region of Uppsala
collaborator UNKNOWN -
Region Örebro County
collaborator OTHER -
Västra Götalandsregionen
collaborator OTHER -
Region Jönköping County
lead OTHER_GOV
Eligibility
- Min Age
- 1 Year
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-09-01
- Primary Completion
- 2030-12-31
- Completion
- 2035-12-31
Countries
- Sweden
Study Locations
More Related Trials
-
Effect of Intravenous Ceftriaxone and Oral Doxycycline for Lyme Neuroborreliosis
NCT00138801 ·Status: COMPLETED ·Phase: PHASE3
-
Direct Diagnosis of Disseminated Lyme Borreliosis.
NCT04719962 ·Status: UNKNOWN ·Phase: NA
-
A Multicenter Study to Evaluate a Borrelia Diagnostic Test in Subjects With Early Stage or Late Stage Lyme Disease
NCT02741609 ·Status: TERMINATED ·Phase: NA
-
Investigation of the Seropersistence of TBE Antibodies and the Booster Response to FSME-IMMUN 0.5 ml in Adults Aged 18 - 67 Years
NCT00161785 ·Status: COMPLETED ·Phase: PHASE4
-
Analysis of Lyme Disease Lesions
NCT00132327 ·Status: COMPLETED
-
Safety, Skin and Plasma Concentration of Azithromycin Dermal Formulation
NCT01243008 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Lyme Test Indication Combinations (LyTIC) Study
NCT03201042 ·Status: TERMINATED
-
Study of Lyme Neuroborreliosis
NCT01635530 ·Status: COMPLETED ·Phase: PHASE4
-
Risk of Exposure and Prevention of Ticks and Tick-borne Diseases Among Foresters in Alsace
NCT06492668 ·Status: RECRUITING
-
A Comprehensive Clinical, Microbiological and Immunological Assessment of Patients With Suspected Post Treatment Lyme Disease Syndrome and Selected Control Populations
NCT00001539 ·Status: RECRUITING
-
Study of the Clinical, Microbiological and Epidemiological Characteristics of Recurrent Imported Borreliosis Confirmed by the CNR Borrelia
NCT07335965 ·Status: RECRUITING
-
Evaluation, Treatment, and Follow-up of Patients With Lyme Disease
NCT00028080 ·Status: RECRUITING
-
Comparing 3 Antibiotic Regimes for Erythema Migrans in General Practice
NCT01368341 ·Status: COMPLETED ·Phase: PHASE4
-
Borrelia Species in Cutaneous Lyme Borreliosis
NCT00576082 ·Status: UNKNOWN
-
Human Anaplasmosis in Eastern France
NCT01013636 ·Status: UNKNOWN
-
Searching for Persistence of Infection in Lyme Disease
NCT01143558 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Borrelia B-cell Diagnostics
NCT06045416 ·Status: RECRUITING
-
Perceptions,Social Representations and Experience of Lyme Borreliosis and Ticks in Adolescents Likely to be Infected and Their Parents
NCT05678478 ·Status: COMPLETED
-
Next Generation Sequencing Detection of Lyme Disease
NCT03505879 ·Status: COMPLETED
-
Xenodiagnosis After Antibiotic Treatment for Lyme Disease
NCT02446626 ·Status: COMPLETED ·Phase: NA
-
Phase 1/2 Lyme Vaccine Study
NCT01504347 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study to Learn About Different Dosing Schedules of a Lyme Disease Vaccine in Healthy Adults
NCT07226882 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of the Safety and Efficacy of Ceftriaxone and Doxycycline in the Treatment of Patients With Seronegative Chronic Lyme Disease
NCT00000938 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Safety and Immunogenicity of mRNA-1975 and mRNA-1982 Against Lyme Disease in Participants 18 Through 70 Years of Age
NCT05975099 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of the Safety and Efficacy of Ceftriaxone and Doxycycline in the Treatment of Patients With Seropositive Chronic Lyme Disease
NCT00001101 ·Status: COMPLETED ·Phase: PHASE3